Total planned funding: $378,965,754
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $378,965,754 |
Organizational Types
NGO | $93,427,781 |
Private Contractor | $84,534,257 |
Own Agency | $55,326,135 |
University | $48,965,908 |
Unknown | $40,208,994 |
Host Country Government Agency | $38,448,528 |
Parastatal | $8,375,031 |
Other USG Agency | $5,200,721 |
Implementing Agency | $2,394,641 |
Multi-lateral Agency | $2,083,758 |
FBO | $0 |
Program Areas
Treatment | $122,411,314 |
Prevention | $79,412,011 |
Care | $76,378,339 |
Governance and Systems | $45,305,612 |
Testing | $28,092,779 |
Management and Operations | $27,365,699 |
Budget Codes
HTXS: Treatment: Adult Treatment | $100,604,539 |
HKID: Care: Orphans and Vulnerable Children | $28,476,844 |
HVCT: Testing: HIV Testing and Counseling | $28,092,779 |
HVMS: Management and Operations | $27,365,699 |
HBHC: Care: Adult Care and Support | $26,175,154 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $21,716,975 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $21,280,137 |
HVOP: Sexual Prevention: Other Sexual Prevention | $21,001,455 |
HVSI: Strategic Information | $20,299,105 |
OHSS: Health Systems Strengthening | $17,797,199 |
HVTB: Care: TB/HIV | $14,920,008 |
HTXD: Treatment: ARV Drugs | $11,997,643 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,234,548 |
PDTX: Treatment: Pediatric Treatment | $9,809,132 |
HLAB: Laboratory Infrastructure | $7,209,308 |
PDCS: Care: Pediatric Care and Support | $6,806,333 |
HMBL: Biomedical Prevention: Blood Safety | $3,571,440 |
HMIN: Biomedical Prevention: Injection Safety | $1,607,456 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$48,917,914
Countries/Regions
Not Available:
$32,575,267
Countries/Regions
USG Aggregated Agencies:
$31,086,221
Countries/Regions